Published Date: 08 Mar 2023
Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.
Read Full NewsRoger discusses how new therapies are transforming asthma treatment, enabling potential clinical remission.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on Phosphorylated tau 181!
Here's some of what is coming soon to NeurologyLive® this week.
Baptist Health Brain & Spine enhances its neurology leadership with Peter Abdelmalik, MD, focusing on patient care, education, and operational efficiency.
A Korean study reveals that adjusted MMSE thresholds significantly increase eligibility for anti-amyloid treatments, highlighting demographic disparities and safety concerns.
New findings reveal the feasibility of self-administering remternetug, a monoclonal antibody for Alzheimer’s, enhancing treatment options for early-stage patients.
Rewriting Airway Disease With Trait-Based Care: 2025’s Convergence of Asthma and COPD Management
1.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
2.
These Athletes Weren't Doping. Their Genes Made It Look Like They Did.
3.
Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality
4.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
5.
GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.
1.
The Unseen Threat: Uncovering the Risks of Pancoast Tumor
2.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
3.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
4.
Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies
5.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
2.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
4.
Efficient Management of First line ALK-rearranged NSCLC - Part II
5.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation